Apple Watch Redesign Gets Early OK As Patent Loss Upheld

By Ryan Davis · March 19, 2026, 7:23 PM EDT

The Federal Circuit on Thursday affirmed a U.S. International Trade Commission decision that found a previous version of the Apple Watch infringes two Masimo blood oxygen monitor patents, but the ruling...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Apple Inc. v. ITC

Case Number

Court

Appellate - Federal Circuit

Nature of Suit

Agency

Date Filed

December 26, 2023

Recent Articles By Ryan

March 10, 2026
Justices Advised To Keep Law Clear In 'Skinny Label' Case
February 26, 2026
Justices Told 'Skinny Label' Case Puts Generic Drugs At Risk
January 20, 2026
Justices To Clarify What's Fair Game With 'Skinny Labels'
January 16, 2026
Supreme Court Takes On Hikma's 'Skinny Label' Patent Case
December 23, 2025
Justices Urged To Spurn SG's Call To Tackle 'Skinny Labels'
December 19, 2025
Squires Issues 21 More Patent Review Denials
December 10, 2025
Apple Tells Fed. Circ. ITC Move Boosts Watch Case Appeal
December 03, 2025
USPTO Gets Earful On Plan To Restrict Patent Reviews
October 30, 2025
Fed. Circ. Explains Rule While Upholding Merck PTAB Loss
October 03, 2025
NIH Sets Patent License Policy Aimed At Promoting Access